Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)

• Publication date: April 2012

The Gastroesophageal Reflux Disease (GERD) Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. A review of causes and concomitant diseases and conditions are also presented. Dosing and treatment cost information is provided for various treatment types. General information on the GERD...

The Gastroesophageal Reflux Disease (GERD) Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. A review of causes and concomitant diseases and conditions are also presented. Dosing and treatment cost information is provided for various treatment types. General information on the GERD market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

Therapy Industry in Asia

OVERVIEW
Overview of the condition
Symptoms
Factors influencing presence and severity
Related injuries
II. PREVALENCE
Prevalence Table: GERD, Reflux & RE (US, Argentina, Brazil, England, Germany, Italy, Sweden, China, Japan, Taiwan, Australia, East Asia, Europe, Western Countries, Worldwide)
III. DIAGNOSIS
Example of diagnosis criteria and diagnostic tests
IV. TREATMENT
Overview
Lifestyle Changes
Antacids
H2 Receptor Antagonists
Proton Pump Inhibitors
Prokinetics
Surgery
V. DOSING AND TREATMENT COSTS
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs
VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals
VII. COMMENTS
VIII. REFERENCES/RESOURCES